TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/26/2025
Back to search
Official data from USPTO
GEN1E LIFESCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
08/27/2025
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
06/29/2023
Registration date
07/30/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/30/2024
Last transaction
08/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/23/2018
First use in commerce
05/23/2018
Drawing code
5
Owner type
03
Owner location
Palo Alto, CA
Examiner
FALK, ERIN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word GEn1E with the letters G and E in upper case, dark blue color font and the letter N and number 1 in lower case, light blue color font, and the word LIFESCIENCES underneath in a smaller font, upper case in dark blue color.
Holders and representatives
Holders
GEn1E Lifesciences Inc.
Representatives
Jessica L. Rothstein Goodwin Procter LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Artificial intelligence powered novel pharmaceutical drug development services
Publications
History of USPTO decisions and trademark events.
19 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/26/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/26/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2024
PUBO
PUBLISHED FOR OPPOSITION
05/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/05/2024
GNRT
NON-FINAL ACTION E-MAILED
04/05/2024
CNRT
NON-FINAL ACTION WRITTEN
04/05/2024
DOCK
ASSIGNED TO EXAMINER
03/14/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2023
NWAP
NEW APPLICATION ENTERED
07/03/2023
Continuous trademark protection
Get notified about every new filing that threatens GEN1E LIFESCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.